Issue 41 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

A brief report sets forth a “new normal,” lets NCI start to streamline clinical trials

NCI’s Doroshow: “These recommendations are something that we can implement right away”

Bertagnolli sets out eight “core principles” for NCI: “We’ve got to be nimbler, faster”

Craig Jordan on discovering tamoxifen’s role in breast cancer—and a lifetime of innovation

Rutgers archives: Shridar Genesan, Tiki Barber, pancreatic cancer retrospectives

In Brief

Gregory Reaman named scientific director of NCI’s Childhood Cancer Data Initiative

Fox Chase, Sylvester collaborate with Pfizer to identify genetic drivers of cancer disparities

UPMC, St. Catherine Specialty Hospital to expand cancer care in Croatia

Cancer organizations endorse initiative to increase lung cancer screening in the U.S.

Funding Opportunities

Theresa Mays’s friends, colleagues establish award for pharmacists submitting abstracts to ASCO

Drugs & Targets

FDA approves Libtayo plus chemotherapy for NSCLC

FDA approves Imjudo + Imfinzi and platinum-based chemo for metastatic NSCLC

FDA approves Adcetris + chemo for pediatric classical Hodgkin lymphoma

Portage Biotech, Merck to collaborate on clinical trial

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login